Why are HCA's executive and board compensation being reduced?

The compensation adjustments are a direct response to the economic uncertainties and challenges presented by the COVID-19 pandemic. The company is implementing these measures to align leadership's financial interests with the broader economic environment and the company's performance during this critical period.

What are the potential payouts for executives under the Senior Officer PEP?

For the EBITDA portion, executives can earn between 25% of their target award for threshold performance and up to 200% for maximum performance. The quality of care portion allows for a 100% payout for target performance, but this is conditional on the company's consolidated EBITDA meeting at least 90% of its target. If the company's EBITDA falls below this threshold, the quality portion payout may be zero.

Are there any safeguards in place for executive compensation under the new program?

Yes, the program includes provisions for clawbacks or adjustments if the company's operating results are restated, or if a participant's conduct is deemed to have negatively impacted the business. The Compensation Committee also retains discretion to adjust program terms in recognition of unusual events or changes in definitions.

HCA 8-K: Leadership Changes

Q: How does the new Senior Officer Performance Excellence Program (Senior Officer PEP) work?

The Senior Officer PEP is designed to incentivize executives based on financial and operational performance. Awards are primarily (80%) tied to achieving specific EBITDA targets and secondarily (20%) to meeting predefined quality of care metrics. Payouts vary based on the level of performance achieved against these targets.

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on April 1, 2020, detailing executive compensation adjustments and the introduction of a new performance program in response to the COVID-19 pandemic. Key decisions include a temporary 30% reduction in base salaries for named and other executive officers from April 1, 2020, through May 31, 2020. Additionally, non-management board members will have their cash compensation retainers waived for the remainder of 2020. The company also launched the 2020 Senior Officer Performance Excellence Program (Senior Officer PEP). This program ties executive awards primarily to EBITDA targets (80%) and secondarily to quality of care metrics (20%). The structure allows for payouts ranging from 25% to 200% of target awards for EBITDA performance, with quality metrics having a more binary payout structure, though subject to EBITDA performance thresholds. These measures reflect HCA's commitment to aligning executive incentives with financial performance and patient care, even amidst an unprecedented public health crisis.

Key Highlights

1Executive officers (including named executive officers) will experience a 30% base salary reduction from April 1, 2020, to May 31, 2020.
2Non-management Board of Directors members will forgo all cash compensation retainers for the period from April 1, 2020, through December 31, 2020.
3HCA has introduced the 2020 Senior Officer Performance Excellence Program (Senior Officer PEP) for its executive officers.
4The Senior Officer PEP award opportunities are weighted 80% towards EBITDA targets and 20% towards quality of care metrics.
5EBITDA performance can result in payouts ranging from 25% (threshold) to 200% (maximum) of the target award.
6Quality of care metrics have a payout of 100% for target performance or higher, but are contingent on overall Company EBITDA meeting at least 90% of its target.
7Awards under the Senior Officer PEP are payable in cash and subject to clawback provisions in cases of financial restatements or misconduct.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 2, 2020)

Summary

Key Highlights

Frequently Asked Questions